Jeil Pharmaceutical Co (XKRX:271980) Long-Term Capital Lease Obligation : ₩3,191 Mil (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Jeil Pharmaceutical Co Long-Term Capital Lease Obligation?

Jeil Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩3,191 Mil.

Jeil Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation declined from Mar. 2024 (₩4,059 Mil) to Jun. 2024 (₩3,616 Mil) and declined from Jun. 2024 (₩3,616 Mil) to Sep. 2024 (₩3,191 Mil).

Jeil Pharmaceutical Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (₩6,617 Mil) to Dec. 2022 (₩5,443 Mil) and declined from Dec. 2022 (₩5,443 Mil) to Dec. 2023 (₩4,452 Mil).

Jeil Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Jeil Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Jeil Pharmaceutical Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

4,636.39

3,506.27

6,617.37

5,442.57

4,452.00

Jeil Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															4,691.71	4,452.00	4,058.70	3,616.48	3,191.37

Jeil Pharmaceutical Co (XKRX:271980) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Jeil Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Jeil Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharmaceutical Co Ltd (XKRX:271980) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

343, Sapyeong-daero, Seocho-gu, Seoul, KOR, 06543

Website

https://www.jeilpharm.co.kr

Jeil Pharmaceutical Co Ltd is engaged in maufacturing and distribution of pharmaceutical products. The company's products include antibiotics, anti-inflammatory painkillers, hepatitis remedies, duodenum ulcer treatments, and anticancer drugs.

Jeil Pharmaceutical Co Headlines

No Headlines